Cargando…

Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays

BACKGROUND: The dramatic increase in use of the IgG test for toxoplasma, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) [TORCH] has led to the requirement for a high-efficiency method that can be used in the clinical laboratory. This study aimed to compare the results of BGI-Array EL...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dongsheng, Wu, Yuanjian, Wang, Liuhong, Xu, Weidong, Zhong, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885771/
https://www.ncbi.nlm.nih.gov/pubmed/24422194
http://dx.doi.org/10.3343/alm.2014.34.1.38
_version_ 1782478822097027072
author Wu, Dongsheng
Wu, Yuanjian
Wang, Liuhong
Xu, Weidong
Zhong, Qiao
author_facet Wu, Dongsheng
Wu, Yuanjian
Wang, Liuhong
Xu, Weidong
Zhong, Qiao
author_sort Wu, Dongsheng
collection PubMed
description BACKGROUND: The dramatic increase in use of the IgG test for toxoplasma, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) [TORCH] has led to the requirement for a high-efficiency method that can be used in the clinical laboratory. This study aimed to compare the results of BGI-Array ELISA TORCH IgG (BGI-GBI, China) screening method to those of Virion/Serion TORCH IgG ELISA (Virion/Serion, Germany). METHODS: Serum specimens (n=400) submitted for routine IgG testing by Virion/Serion ELISA were also tested using the BGI-Array ELISA method. The agreements of these two kinds of method were analyzed by κ-coefficients calculation. RESULTS: Following repeat testing, the BGI-Array ELISA TORCH IgG assays demonstrated agreements of 99.5% (398/400 specimens), 98% (392/400 specimens), 99% (396/400 specimens), and 99.5% (398/400 specimens), respectively. The BGI-Array ELISA IgG assays provided results comparable to Virion/Serion ELISA results, with κ-coefficients showing near-perfect agreement for the HSV (κ=0.87), rubella (κ=0.92) and CMV (κ=0.93) and substantial agreement for the toxoplasma (κ=0.80) IgG assays. The use of the BGI-Array ELISA TORCH IgG assays could reduce the turnaround time (1.5 hr vs. 5 hr by Virion/Serion ELISA for 100 specimens) and were easy to use. CONCLUSIONS: BGI-Array ELISA TORCH IgG shows a good agreement with Virion/Serion ELISA methods and is suitable for clinical application.
format Online
Article
Text
id pubmed-3885771
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Society for Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-38857712014-01-13 Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays Wu, Dongsheng Wu, Yuanjian Wang, Liuhong Xu, Weidong Zhong, Qiao Ann Lab Med Original Article BACKGROUND: The dramatic increase in use of the IgG test for toxoplasma, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) [TORCH] has led to the requirement for a high-efficiency method that can be used in the clinical laboratory. This study aimed to compare the results of BGI-Array ELISA TORCH IgG (BGI-GBI, China) screening method to those of Virion/Serion TORCH IgG ELISA (Virion/Serion, Germany). METHODS: Serum specimens (n=400) submitted for routine IgG testing by Virion/Serion ELISA were also tested using the BGI-Array ELISA method. The agreements of these two kinds of method were analyzed by κ-coefficients calculation. RESULTS: Following repeat testing, the BGI-Array ELISA TORCH IgG assays demonstrated agreements of 99.5% (398/400 specimens), 98% (392/400 specimens), 99% (396/400 specimens), and 99.5% (398/400 specimens), respectively. The BGI-Array ELISA IgG assays provided results comparable to Virion/Serion ELISA results, with κ-coefficients showing near-perfect agreement for the HSV (κ=0.87), rubella (κ=0.92) and CMV (κ=0.93) and substantial agreement for the toxoplasma (κ=0.80) IgG assays. The use of the BGI-Array ELISA TORCH IgG assays could reduce the turnaround time (1.5 hr vs. 5 hr by Virion/Serion ELISA for 100 specimens) and were easy to use. CONCLUSIONS: BGI-Array ELISA TORCH IgG shows a good agreement with Virion/Serion ELISA methods and is suitable for clinical application. The Korean Society for Laboratory Medicine 2014-01 2013-12-06 /pmc/articles/PMC3885771/ /pubmed/24422194 http://dx.doi.org/10.3343/alm.2014.34.1.38 Text en © The Korean Society for Laboratory Medicine. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Wu, Dongsheng
Wu, Yuanjian
Wang, Liuhong
Xu, Weidong
Zhong, Qiao
Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays
title Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays
title_full Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays
title_fullStr Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays
title_full_unstemmed Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays
title_short Evaluation of a Novel Array-Based Toxoplasma, Rubella, Cytomegalovirus, and Herpes Simplex Virus IgG Enzyme Linked Immunosorbent Assay and Its Comparison with Virion/Serion Enzyme Linked Immunosorbent Assays
title_sort evaluation of a novel array-based toxoplasma, rubella, cytomegalovirus, and herpes simplex virus igg enzyme linked immunosorbent assay and its comparison with virion/serion enzyme linked immunosorbent assays
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885771/
https://www.ncbi.nlm.nih.gov/pubmed/24422194
http://dx.doi.org/10.3343/alm.2014.34.1.38
work_keys_str_mv AT wudongsheng evaluationofanovelarraybasedtoxoplasmarubellacytomegalovirusandherpessimplexvirusiggenzymelinkedimmunosorbentassayanditscomparisonwithvirionserionenzymelinkedimmunosorbentassays
AT wuyuanjian evaluationofanovelarraybasedtoxoplasmarubellacytomegalovirusandherpessimplexvirusiggenzymelinkedimmunosorbentassayanditscomparisonwithvirionserionenzymelinkedimmunosorbentassays
AT wangliuhong evaluationofanovelarraybasedtoxoplasmarubellacytomegalovirusandherpessimplexvirusiggenzymelinkedimmunosorbentassayanditscomparisonwithvirionserionenzymelinkedimmunosorbentassays
AT xuweidong evaluationofanovelarraybasedtoxoplasmarubellacytomegalovirusandherpessimplexvirusiggenzymelinkedimmunosorbentassayanditscomparisonwithvirionserionenzymelinkedimmunosorbentassays
AT zhongqiao evaluationofanovelarraybasedtoxoplasmarubellacytomegalovirusandherpessimplexvirusiggenzymelinkedimmunosorbentassayanditscomparisonwithvirionserionenzymelinkedimmunosorbentassays